CN1305505C - Medicament for treating prostatauxe inflammation - Google Patents
Medicament for treating prostatauxe inflammation Download PDFInfo
- Publication number
- CN1305505C CN1305505C CNB2005100866240A CN200510086624A CN1305505C CN 1305505 C CN1305505 C CN 1305505C CN B2005100866240 A CNB2005100866240 A CN B2005100866240A CN 200510086624 A CN200510086624 A CN 200510086624A CN 1305505 C CN1305505 C CN 1305505C
- Authority
- CN
- China
- Prior art keywords
- parts
- inflammation
- medicament
- prostatauxe
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicament for treating prostatauxe inflammation, which is a Chinese patent medicine chiefly treating prostatauxe, inflammation, hyperplasia and urethral calculus and taking the Chinese herbal medicine as the raw material. The medicament is made from broomrape, silkworm larva, conic gymnadenia tuber, morinda root, psoralea fruit, lucid asparagus, felicitous plant glossy ganoderma, schisandra fruit, astragalus root, eaglewood wood and cowherb seed. The present invention can treat and radically cure prostatauxe, inflammation and proliferative and has good therapeutic effect on urethral calculus.
Description
Technical field
The present invention relates to a kind of medicament for the treatment of prostatauxe inflammation, is that a kind of main treatment prostate hyperplasia, inflammation, hypertrophy and calculus of urethra are the Chinese patent medicine of raw material with the Chinese herbal medicine.
Background technology
Prostate hyperplasia, inflammation, hypertrophy are a kind of old people's commonly encountered diseases, as early treatment not, can make the bladder muscle plumpness, make the urethra distortion, increase the contractility of bladder, just can make urethra pass through to block and discharge, go down for a long time, bladder loses contractility, urine backflow ureter, cause ureter to enlarge, kidney is simultaneously loose, and atrophy causes that pollakiuria, incontinence, inflammation, related symptoms such as hemorrhage take place, serious can't take care of oneself, even causes the uremic card and death.Current, treatment prostate hyperplasia, inflammation, hypertrophy Western medicine commonly used and operation, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, and operation increases the patient suffering, and can not effect a radical cure.Utilization Chinese herbal treatment or auxiliary smelting treatment prostate hyperplasia, inflammation, hypertrophy are the work of always studying, but present medicine can only alleviate the patient suffering, can not effect a radical cure, and curative effect can not be satisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of prostatauxe inflammation, can treat and effect a radical cure prostate hyperplasia, inflammation and hypertrophy, and calculus of urethra is also had better curative effect.
Solution of the present invention is according to the rule of the traditional Chinese medical science to prostate hyperplasia, inflammation, hypertrophy treatment, be the body resistance strengthening and constitution consolidating, the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, the detoxifcation pain relieving, hard masses softening and resolving and dampness removing fluid-purging therapy, the present invention forms according to above-mentioned rule, can the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, the detoxifcation pain relieving again can the body resistance strengthening and constitution consolidating, hard masses softening and resolving.Herba Cistanches of the present invention, Fructus Psoraleae and Fructus Schisandrae Chinensis are gone into the heart, lung, liver three warps, be used to invigorate blood circulation, and invigorating the liver and kidney, blood circulation regulating, removing blood stasis with potent drugs is by blood; The strong waist knee joint of Radix Morindae Officinalis, reuniting the fractured tendons and bones; The Bombyx Batryticatus wind-damp dispelling, dampness is stimulated the menstrual flow, and is relieving convulsion, wind-transformation expectorant; The Semen Vaccariae promoting the circulation of blood is stimulated the menstrual flow, removing blood stasis with potent drugs pursues blood, the long-pending painful abdominal mass that disappears of mill, detumescence convergence; Lignum Aquilariae Resinatum, Ganoderma lucidum seu Japonicum warming spleen and stomach for dispelling cold, analgesia, Shujin, suppressing the hyperactive liver and easing the stomach; Rhizoma Gymnadeniae, Radix Astragali benefiting vital QI and blood, promoting the production of body fluid to quench thirst, promoting pus discharge and tissue regeneration strengthening, invigorating QI to consolidate the body surface resistance, diuresis detoxifcation; Have eliminating evil just the wound, set upright and do not stay heresy, the kidney invigorating collateral dredging, warm network blood-activating analgetic, hard masses softening and resolving makes the function of fortuneization urine diuresis, is antiinflammatory, the medicament of the edema of dispelling, diuresis, the kidney invigorating water, has the sick effect of good radical cure.
The present invention is made by the following weight proportion raw material:
18～27 parts of 18～27 parts of Rhizoma Gymnadeniaes of 36～45 portions of Bombyx Batryticatus of Herba Cistanches
22～33 parts of 26～39 parts of Radix Asparagi of 18～27 parts of Fructus Psoraleaes of Radix Morindae Officinalis
24～35 parts of 28～38 parts of Radixs Astragali of 20～30 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
16～24 parts of 16～24 parts of Semen Vaccariae of Lignum Aquilariae Resinatum.
The weight proportion of each raw material of formula optimization of the present invention is:
20～25 parts of 20～25 parts of Rhizoma Gymnadeniaes of 38～43 portions of Bombyx Batryticatus of Herba Cistanches
25～29 parts of 29～36 parts of Radix Asparagi of 20～25 parts of Fructus Psoraleaes of Radix Morindae Officinalis
26～32 parts of 30～36 parts of Radixs Astragali of 22～28 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
The weight proportion of best each raw material of prescription of the present invention is:
23 parts of 23 parts of Rhizoma Gymnadeniaes of 40 portions of Bombyx Batryticatus of Herba Cistanches
27 parts of 32 parts of Radix Asparagi of 23 parts of Fructus Psoraleaes of Radix Morindae Officinalis
29 parts of 33 parts of Radixs Astragali of 25 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
20 parts of 20 parts of Semen Vaccariae of Lignum Aquilariae Resinatum.
The present invention can be made into capsule, being called " pills for prostate disease " method for making is to get Bombyx Batryticatus earlier, Rhizoma Gymnadeniae and Ganoderma lucidum seu Japonicum drying and crushing to 120～200 order fine powders, getting all the other each raw materials again decocts with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, and the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, the leaching supernatant reclaims ethanol, is concentrated into the clear paste of relative density 1.30～1.32 when 50 degree～55 are spent, again with clear paste and Bombyx Batryticatus, Rhizoma Gymnadeniae and Ganoderma lucidum seu Japonicum fine powder mixing, drying is ground into fine powder, incapsulates.Every adorn 0.35 the gram, oral usually, one time 2～3, a twice-daily.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes comprehensive function treatment prostate hyperplasia, inflammation, the hypertrophy of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity test underproof animal end sees any toxic reaction, its main organs does not have tangible change yet, and mice is 40g crude drug/kg to the maximum tolerated dose of medicine of the present invention, is 156 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins, glucose, phlegmatic temperament, organic acid, fatty oil, ginsenoside, vitamin and nearly tens seed amino acids in the medicine, also contain various trace elements such as potassium, zinc, calcium, ferrum, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can treat and effect a radical cure prostate hyperplasia, inflammation, hypertrophy effectively, and calculus of urethra is also had better curative effect, has improved patient's life quality and the time greatly, and higher healing rehabilitation efficacy is arranged.
For showing medicine of the present invention, as follows through clinical test results to prostate hyperplasia, inflammation, outgrowth therapeutic effect; Treat various prostate hyperplasia, inflammation, hypertrophy patient's 67 examples, radical cure rehabilitation 45 examples, produce effects 12 examples, effective 3 examples, invalid 7 examples, effective percentage reaches more than 89%.Treatment calculus of urethra 40 examples, radical cure rehabilitation 20 examples, produce effects 8 examples, effective 3 examples, invalid 9 examples, effective percentage reaches more than 77%.
The specific embodiment
Take by weighing raw material by following proportioning: Herba Cistanches 40g, Bombyx Batryticatus 23g, Rhizoma Gymnadeniae 23g, Radix Morindae Officinalis 23g Fructus Psoraleae 32g, Radix Asparagi 27g, Ganoderma lucidum seu Japonicum 25g, Fructus Schisandrae Chinensis 33g, Radix Astragali 29g, Lignum Aquilariae Resinatum 20g, Semen Vaccariae 20g.
Production method is as follows: get Bombyx Batryticatus earlier, Rhizoma Gymnadeniae and Ganoderma lucidum seu Japonicum drying and crushing to 120～200 order fine powders, getting all the other each raw materials again decocts with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill the leaching supernatant 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Bombyx Batryticatus, Rhizoma Gymnadeniae and Ganoderma lucidum seu Japonicum fine powder mixing, drying, be ground into fine powder, incapsulate.Every adorn 0.35 the gram, oral usually, one time 2～3, a twice-daily.
Claims (3)
1, a kind of medicament for the treatment of prostatauxe inflammation is characterized in that it is made by the following weight proportion raw material:
18～27 parts of 18～27 parts of Rhizoma Gymnadeniaes of 36～45 portions of Bombyx Batryticatus of Herba Cistanches
22～33 parts of 26～39 parts of Radix Asparagi of 18～27 parts of Fructus Psoraleaes of Radix Morindae Officinalis
24～35 parts of 28～38 parts of Radixs Astragali of 20～30 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
16～24 parts of 16～24 parts of Semen Vaccariae of Lignum Aquilariae Resinatum.
2, a kind of medicament for the treatment of prostatauxe inflammation according to claim 1, wherein the weight proportion of each raw material is:
20～25 parts of 20～25 parts of Rhizoma Gymnadeniaes of 38～43 portions of Bombyx Batryticatus of Herba Cistanches
25～29 parts of 29～36 parts of Radix Asparagi of 20～25 parts of Fructus Psoraleaes of Radix Morindae Officinalis
26～32 parts of 30～36 parts of Radixs Astragali of 22～28 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
18～22 parts of 18～22 parts of Semen Vaccariae of Lignum Aquilariae Resinatum.
3, a kind of medicament for the treatment of prostatauxe inflammation according to claim 1, wherein the weight proportion of each raw material is:
23 parts of 23 parts of Rhizoma Gymnadeniaes of 40 portions of Bombyx Batryticatus of Herba Cistanches
27 parts of 32 parts of Radix Asparagi of 23 parts of Fructus Psoraleaes of Radix Morindae Officinalis
29 parts of 33 parts of Radixs Astragali of 25 parts of Fructus Schisandrae Chinensis of Ganoderma lucidum seu Japonicum
20 parts of 20 parts of Semen Vaccariae of Lignum Aquilariae Resinatum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100866240A CN1305505C (en) | 2005-10-17 | 2005-10-17 | Medicament for treating prostatauxe inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100866240A CN1305505C (en) | 2005-10-17 | 2005-10-17 | Medicament for treating prostatauxe inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1745814A CN1745814A (en) | 2006-03-15 |
| CN1305505C true CN1305505C (en) | 2007-03-21 |
Family
ID=36165632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100866240A Expired - Fee Related CN1305505C (en) | 2005-10-17 | 2005-10-17 | Medicament for treating prostatauxe inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305505C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101204532B (en) * | 2007-12-19 | 2010-08-11 | 孙义岭 | Medicine for prostate disease and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1227751A (en) * | 1998-10-14 | 1999-09-08 | 马国勇 | Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof |
| CN1374107A (en) * | 2001-12-29 | 2002-10-16 | 郑国芃 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
-
2005
- 2005-10-17 CN CNB2005100866240A patent/CN1305505C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1227751A (en) * | 1998-10-14 | 1999-09-08 | 马国勇 | Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof |
| CN1374107A (en) * | 2001-12-29 | 2002-10-16 | 郑国芃 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1745814A (en) | 2006-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
| CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
| CN100500201C (en) | Chinese herbal medicine for treating prostatitis | |
| CN103520680A (en) | Traditional Chinese medicine for treating acute heart failure | |
| CN102988675B (en) | Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof | |
| CN103041262B (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
| CN101607067B (en) | Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof | |
| CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
| CN1305505C (en) | Medicament for treating prostatauxe inflammation | |
| CN1895357A (en) | Chinese medicine for treating kidney insufficiency | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN100398143C (en) | Medicament for treating vitiligo | |
| CN1322871C (en) | Preparation of compound pseudo-ginseng drop pellets for treating traumatologic disease | |
| CN100496542C (en) | Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation | |
| CN101301407B (en) | Medicament for treating arthritis and angiitis | |
| CN100348252C (en) | Chinese medicinal product for protecting liver and freezing bowel | |
| CN1209130C (en) | Medicament for treating femoral head necrosis | |
| CN1305508C (en) | Pill for treating coronary heart disease | |
| CN1177605C (en) | Pill for treating rheumatic heart disease | |
| CN101890069A (en) | Medicament for preventing and treating gout and preparation process thereof | |
| CN101954018A (en) | Oral medicament for treating chronic nephritis | |
| CN100556438C (en) | A kind of medicine for external application for the treatment of herpes zoster | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20091117 |